Simona Lapusan

2.2k total citations
33 papers, 676 citations indexed

About

Simona Lapusan is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Simona Lapusan has authored 33 papers receiving a total of 676 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 8 papers in Oncology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Simona Lapusan's work include Acute Myeloid Leukemia Research (15 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Simona Lapusan is often cited by papers focused on Acute Myeloid Leukemia Research (15 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Simona Lapusan collaborates with scholars based in France, Italy and United Kingdom. Simona Lapusan's co-authors include Ollivier Legrand, Mohamad Mohty, Pierre Hirsch, Christophe Marzac, Anne Vekhoff, Ruoping Tang, Jean‐Pierre Marie, Marie Thérèse Rubio, Zora Marjanovic and Bernard Rio and has published in prestigious journals such as Blood, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Simona Lapusan

32 papers receiving 666 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simona Lapusan France 15 350 271 146 124 109 33 676
Amer Beitinjaneh United States 15 286 0.8× 337 1.2× 146 1.0× 84 0.7× 106 1.0× 64 696
Mahasweta Gooptu United States 16 432 1.2× 201 0.7× 123 0.8× 103 0.8× 192 1.8× 66 683
Eugenia Giraldi Italy 11 518 1.5× 247 0.9× 288 2.0× 153 1.2× 171 1.6× 22 885
Ivan Moiseev Russia 13 336 1.0× 209 0.8× 84 0.6× 105 0.8× 143 1.3× 149 611
Christoph Scheid Germany 12 359 1.0× 154 0.6× 151 1.0× 149 1.2× 65 0.6× 37 573
Sameem Abedin United States 18 378 1.1× 220 0.8× 332 2.3× 91 0.7× 187 1.7× 68 890
Kyung‐Nam Koh South Korea 14 297 0.8× 151 0.6× 60 0.4× 76 0.6× 166 1.5× 89 660
Marco Rabusin Italy 15 359 1.0× 125 0.5× 133 0.9× 213 1.7× 195 1.8× 43 818
Paola Carluccio Italy 15 412 1.2× 138 0.5× 159 1.1× 176 1.4× 92 0.8× 45 612
Asmita Mishra United States 15 411 1.2× 234 0.9× 187 1.3× 87 0.7× 72 0.7× 63 672

Countries citing papers authored by Simona Lapusan

Since Specialization
Citations

This map shows the geographic impact of Simona Lapusan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simona Lapusan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simona Lapusan more than expected).

Fields of papers citing papers by Simona Lapusan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simona Lapusan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simona Lapusan. The network helps show where Simona Lapusan may publish in the future.

Co-authorship network of co-authors of Simona Lapusan

This figure shows the co-authorship network connecting the top 25 collaborators of Simona Lapusan. A scholar is included among the top collaborators of Simona Lapusan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simona Lapusan. Simona Lapusan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Genthon, Alexis, Thibault Chiarabini, Nadia Valin, et al.. (2021). Severe COVID-19 infection in a patient with paroxysmal nocturnal hemoglobinuria on eculizumab therapy. Leukemia & lymphoma. 62(6). 1502–1505. 9 indexed citations
2.
Duléry, Rémy, Zora Marjanovic, Simona Lapusan, et al.. (2021). Role of D(T)PACE-based regimens as treatment of multiple myeloma with extramedullary relapse or refractory disease. Leukemia & lymphoma. 62(9). 2235–2241. 4 indexed citations
3.
Genthon, Alexis, Éolia Brissot, Florent Malard, et al.. (2020). Gemtuzumab Ozogamicin Combined With Intensive Chemotherapy in Patients With Acute Myeloid Leukemia Relapsing After Allogenic Stem Cell Transplantation. Clinical Lymphoma Myeloma & Leukemia. 20(12). 791–796. 4 indexed citations
4.
Labopin, Myriam, Anne‐Claire Mamez, Simona Lapusan, et al.. (2019). Fractionated gemtuzumab ozogamicin in association with high dose chemotherapy: a bridge to allogeneic stem cell transplantation in refractory and relapsed acute myeloid leukemia. Bone Marrow Transplantation. 55(2). 452–460. 11 indexed citations
5.
Picod, Adrien, Agnès Bonnin, Giorgia Battipaglia, et al.. (2018). Defibrotide for Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease Prophylaxis in High-Risk Adult Patients: A Single-Center Experience Study. Biology of Blood and Marrow Transplantation. 24(7). 1471–1475. 19 indexed citations
7.
Hirsch, Pierre, Ruoping Tang, Nasséra Abermil, et al.. (2017). Precision and prognostic value of clone-specific minimal residual disease in acute myeloid leukemia. Haematologica. 102(7). 1227–1237. 38 indexed citations
9.
Lapusan, Simona, et al.. (2015). The impact of allogeneic-hematopoietic stem cell transplantation on patients' and close relatives' quality of life and relationships. European Journal of Oncology Nursing. 21. 248–256. 39 indexed citations
11.
Guitard, J., Éric Dannaoui, Bernard Rio, et al.. (2013). Acremonium sclerotigenum-Acremonium egyptiacum: a multi-resistant fungal pathogen complicating the course of aplastic anaemia. Clinical Microbiology and Infection. 20(1). O30–O32. 10 indexed citations
14.
Haïat, Stéphanie, Zora Marjanovic, Simona Lapusan, et al.. (2010). Outcome of 40 adults aged from 18 to 55 years with acute lymphoblastic leukemia treated with double-delayed intensification pediatric protocol. Leukemia Research. 35(1). 66–72. 22 indexed citations
15.
Tang, Ruoping, Pierre Hirsch, Fanny Fava, et al.. (2009). High Id1 expression is associated with poor prognosis in 237 patients with acute myeloid leukemia. Blood. 114(14). 2993–3000. 43 indexed citations
16.
Béziat, Vivien, Stéphanie Nguyen, Simona Lapusan, et al.. (2009). Fully functional NK cells after unrelated cord blood transplantation. Leukemia. 23(4). 721–728. 44 indexed citations
17.
Hirsch, Pierre, R. Tang, Simona Lapusan, et al.. (2009). High Id1 Expression Is Associated with Poor Prognosis in 237 Patients with Acute Myeloid Leukemia.. Blood. 114(22). 4687–4687. 3 indexed citations
18.
Koscielny, Serge, et al.. (2008). Primary mediastinal large B-cell lymphomas treated with dose-intensified CHOP alone or CHOP combined with radiotherapy. Leukemia & lymphoma. 49(8). 1510–1515. 11 indexed citations
19.
Girinsky, T., Simona Lapusan, Vincent Ribrag, et al.. (2005). Phase II study of concomitant chemoradiotherapy in bulky refractory or chemoresistant relapsed lymphomas. International Journal of Radiation Oncology*Biology*Physics. 61(2). 476–479. 14 indexed citations
20.
Oprea, Corina, Călin Cainap, R. Azoulay, et al.. (2005). Primary diffuse large B‐cell non‐Hodgkin lymphoma of the paranasal sinuses: a report of 14 cases. British Journal of Haematology. 131(4). 468–471. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026